NYSE:SOLV Solventum Q3 2026 Earnings Date & Estimates $87.79 +1.38 (+1.60%) As of 10:36 AM Eastern This is a fair market value price provided by Massive. Learn more. Solventum is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 5, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Solventum in Q3 2026Solventum is expected to post earnings of $1.35 per share on revenue of $1.93 billion. In the same quarter a year earlier Solventum reported $1.50 per share on revenue of $2.10 billion. Solventum last reported on August 5, 2026, posting $2.55 per share and beating the $1.91 consensus estimate. Solventum has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS$1.35Expected Revenue$1.93 billionPrior-Year EPS$1.50Prior-Year Revenue$2.10 billionExpected EPS Growth-10.0%Expected Revenue Growth-7.7%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$2.55 (Beat by +$0.64)Last Quarter Revenue$2.21 billionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Solventum Q3 2026 Earnings FAQ When does Solventum report Q3 2026 earnings? Solventum (NYSE:SOLV) is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. What time is Solventum's Q3 2026 earnings call? Solventum's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Solventum? Analysts expect Solventum to post earnings of $1.35 per share for Q3 2026. How much revenue is Solventum expected to report? The consensus revenue estimate for Solventum is $1.93 billion for Q3 2026. Solventum Earnings HeadlinesA new coolest thing made in Minnesota has been namedOctober 8 at 7:57 PM | yahoo.comBair Hugger Warming System wins 2026 'Coolest Thing Made in Minnesota'October 7 at 6:54 PM | msn.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.October 9 at 1:00 AM | Banyan Hill Publishing (Ad)'Bair Hugger' wins 2026 coolest thing in Minnesota awardOctober 6 at 8:16 PM | msn.com‘Coolest thing’ made in Minnesota crowned after weeks of votingOctober 6 at 8:16 PM | yahoo.comContrasting SS Innovations International (NASDAQ:SSII) and Solventum (NYSE:SOLV)October 4, 2026 | americanbankingnews.comSee More Solventum Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Solventum? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Solventum and other key companies, straight to your email. Email Address About SolventumSolventum (NYSE:SOLV) (NYSE:SOLV) is a global healthcare company that develops products, technologies and services designed to support clinical care, healthcare operations and patient outcomes. The company serves healthcare providers, dental professionals, laboratories, manufacturers and other organizations. Solventum’s portfolio includes medical and surgical products such as wound-care systems, surgical drapes, sterilization and infection-prevention solutions, and patient-monitoring or fixation products. Its Dental Solutions business provides products used in preventive, restorative and orthodontic care, while its Health Information Systems business offers software and services that support clinical documentation, coding, revenue-cycle management and other healthcare administrative functions. The company also develops purification and filtration technologies for healthcare, life sciences and other industrial applications. Solventum began operating as an independent public company on April 1, 2024, following its separation from 3M. It serves customers in markets around the world. Bryan Hanson is Solventum’s president and chief executive officer.View Solventum ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Applied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt LoadJetBlue's LaGuardia Win Could Change Its Financial FutureConstellation Brands Beat Earnings, But Beer Demand Is Still a Problem Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
